The University of Virginia’s Center for Diabetes Technology Licenses Klue’s Meal Detection Technology to Advance Diabetes Treatment
Summary
The UVA Center for Diabetes Technology is licensing Klue’s patented gesture sensing and behavioral analytics software and will be validating Klue’s mealtime insulin reminder application in a 12-week randomized clinical trial. “Technologies like Klue added to novel closed loop insulin dosing algorithms could get us closer to the advanced autonomous systems patients have been asking for,” Breton adds. “First, there is of course the promise of reaching the holy grail; a fully autonomous artificial pancreas system, but we also see other companies looking for innovative and effective ways to engage their consumers consider our platform to roll out novel, data-informed services and solutions that help people with diabetes live their healthiest and happiest life.” Klue is a digital health technology company developing a groundbreaking operating system for behavior change and real-time digital therapeutics. Initially focused on the ability to detect when and how a user eats and drinks, Klue is building a platform that elevates the more important consumption patterns and acts “in-the-moment” when the impact is the biggest. We empower our partners to create more insightful, real-time engagements and roll out new products, services and programs that leverage the unique, clinically validated capabilities of our platform.
Classifications
AskAI Classifications
LabelsLinked Companies
